They reported that antioxidant enzymes, including SOD1 and SOD2, catalase, and heme oxygenase 1, are markedly upregulated in actively demyelinating MS lesions compared to normal-appearing white matter and white matter tissue of the control brains. This evidence concerns the gene SOD1 and myeloid sarcoma.